These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 33312335)

  • 1. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
    Nunomura A; Perry G
    Oxid Med Cell Longev; 2020; 2020():2638130. PubMed ID: 33312335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.
    Swarbrick S; Wragg N; Ghosh S; Stolzing A
    Mol Neurobiol; 2019 Sep; 56(9):6156-6167. PubMed ID: 30734227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
    Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
    J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease.
    Wong HK; Veremeyko T; Patel N; Lemere CA; Walsh DM; Esau C; Vanderburg C; Krichevsky AM
    Hum Mol Genet; 2013 Aug; 22(15):3077-92. PubMed ID: 23585551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.
    Shioya M; Obayashi S; Tabunoki H; Arima K; Saito Y; Ishida T; Satoh J
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):320-30. PubMed ID: 20202123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice.
    Zhang R; Zhang Q; Niu J; Lu K; Xie B; Cui D; Xu S
    J Neurol Sci; 2014 Mar; 338(1-2):57-64. PubMed ID: 24423585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
    Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
    Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular network of microRNA targets in Alzheimer's disease brains.
    Satoh J
    Exp Neurol; 2012 Jun; 235(2):436-46. PubMed ID: 21945006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain.
    Lukiw WJ; Alexandrov PN
    Mol Neurobiol; 2012 Aug; 46(1):11-9. PubMed ID: 22302353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
    Chum PP; Bishara MA; Solis SR; Behringer EJ
    J Alzheimers Dis; 2024; 99(s2):S187-S234. PubMed ID: 37458037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide profiling and predicted significance of post-mortem brain microRNA in Alzheimer's disease.
    Henriques AD; Machado-Silva W; Leite REP; Suemoto CK; Leite KRM; Srougi M; Pereira AC; Jacob-Filho W; Nóbrega OT;
    Mech Ageing Dev; 2020 Oct; 191():111352. PubMed ID: 32920076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microRNAs in understanding sex-based differences in Alzheimer's disease.
    Llera-Oyola J; Carceller H; Andreu Z; Hidalgo MR; Soler-Sáez I; Gordillo F; Gómez-Cabañes B; Roson B; de la Iglesia-Vayá M; Mancuso R; Guerini FR; Mizokami A; García-García F
    Biol Sex Differ; 2024 Jan; 15(1):13. PubMed ID: 38297404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
    Kong Y; Wu J; Yuan L
    Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.
    Wang LL; Min L; Guo QD; Zhang JX; Jiang HL; Shao S; Xing JG; Yin LL; Liu JH; Liu R; Guo SL
    Biomed Res Int; 2017; 2017():8030369. PubMed ID: 29057267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
    Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
    Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity.
    Sarkar S; Jun S; Rellick S; Quintana DD; Cavendish JZ; Simpkins JW
    Brain Res; 2016 Sep; 1646():139-151. PubMed ID: 27235866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).
    Pogue AI; Lukiw WJ
    Cell Mol Neurobiol; 2018 Jul; 38(5):1021-1031. PubMed ID: 29302837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNAs in Alzheimer Disease - A Therapeutic Perspective.
    Gupta P; Bhattacharjee S; Sharma AR; Sharma G; Lee SS; Chakraborty C
    Curr Alzheimer Res; 2017; 14(11):1198-1206. PubMed ID: 28847283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-146a Dysregulates Energy Metabolism During Neuroinflammation.
    Kim SJ; Russell AE; Wang W; Gemoets DE; Sarkar SN; Simpkins JW; Brown CM
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):228-241. PubMed ID: 34028667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.